Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features

Lasers Surg Med. 2005 Jun;36(5):377-82. doi: 10.1002/lsm.20186.

Abstract

Background and objectives: We aimed to treat different pathologic types of basal cell carcinomas (BCCs) using photodynamic therapy (PDT).

Study design/materials and methods: Thirty lesions in six patients underwent PDT. The photosensitizer used was Photoheme, a hematoporphyrin derivative IX. It was injected intravenously at the dose of 2-3.25 mg/kg. After 24 hours, the lesions were illuminated by laser light (lambda = 632 nm, light exposure dose = 100-200 J/cm2). Lesions were evaluated pre and post-operatively and at follow-up sessions (of up to 6 months).

Results: After a single session of PDT, the average response rate in different histopathologic kinds of basal cell carcinoma (e.g., ulcerative, superficial, nodular, and pigmented forms) were 100%, 62%, 90%, and 14%, respectively. In patients who responded completely, the cosmetic results were excellent and there were no recurrence at 6th month of follow-up.

Conclusion: Although PDT seems to be an effective treatment modality for superficial, ulcerative, and nodular BCCs, it is not recommended for pigmented lesions.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Basal Cell Carcinoma / drug therapy*
  • Basal Cell Carcinoma / pathology
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / pathology
  • Hematoporphyrin Derivative / administration & dosage
  • Hematoporphyrin Derivative / therapeutic use*
  • Hematoporphyrin Photoradiation*
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Photosensitizing Agents
  • Hematoporphyrin Derivative